HOME PAGE
  NEWS
  PUBLICATIONS
  COMPANY OVERVIEW
  THERAPEUTIC APPLICATIONS
  REFERENCES
  PRODUCTS

RESERVED AREA
REGISTER

 THERAPEUTIC APPLICATIONS


 Nutraceutics
 
AISA 5203-L is one of four patented molecules which will be tested on a panel of healthy subjects aged 65-85 years, under the framework of a EU Capacities project (FP7) RISTOMED 222230, as a nutraceutical food integrator aimed at lowering inflammatory and methabolic disease markers and increasing wellness (anti-stress effects).

RISTOMED
results will be available in the summer of 2011; development and commercialization on the OTC nutraceutical market is envisioned for 2012.

Applications:
Human chronic inflammatory diseases, degenerative diseases, tissue repair and stress treatment, i.e.: anti-aging treatment by nutrition for the elderly.

 Cosmetics and cosmeceutics
  In young skin(1), cellular stress is
reversible, not anymore in aged skin(2).

With AISA supplementation, cellular
stress becomes reversible.
  


Potential applications include:
  • inflammatory traits of ageing,
  • non pathologic stress,
  • visible delay of cell senescence, consistent with counteracting the ageing process.





  AISA Therapeutics
Headquarters Genopole Entreprises - 4, rue Pierre Fontaine 91058 EVRY (F)
Postal address Biopark Campus Cancer 1, mail du Pr Georges Mathé 94807 - Villejuif (F)
Tel/Fax +33 (0) 1 78 40 04 38 · email: info@aisa-tx.com